BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8443393)

  • 41. The relationship between argyrophilic proteins and some immunophenotypic markers in acute leukemia cells.
    Klobusická M; Babusíková O
    Neoplasma; 1997; 44(6):356-60. PubMed ID: 9605007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia.
    Quijano CA; Moore D; Arthur D; Feusner J; Winter SS; Pallavicini MG
    Leukemia; 1997 Sep; 11(9):1508-15. PubMed ID: 9305606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia.
    Uckun FM; Gajl-Peczalska KJ; Kersey JH; Houston LL; Vallera DA
    J Exp Med; 1986 Feb; 163(2):347-68. PubMed ID: 3511171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of CD24 on CD19- CD79a+ early B-cell progenitors in human bone marrow.
    Israel E; Kapelushnik J; Yermiahu T; Levi I; Yaniv I; Shpilberg O; Shubinsky G
    Cell Immunol; 2005; 236(1-2):171-8. PubMed ID: 16181617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Proportions of cells expressing CD38-/CD34+, CD38+/CD34+, CD19+/CD34+, or CD13,33+/CD34+ in the regenerating bone marrows during complete remission of acute leukemia or after bone marrow transplantation].
    Kahng J; Shin SY; Han K
    Korean J Lab Med; 2007 Dec; 27(6):406-13. PubMed ID: 18160830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia.
    Manabe A; Coustan-Smith E; Behm FG; Raimondi SC; Campana D
    Blood; 1992 May; 79(9):2370-7. PubMed ID: 1373973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of tumor necrosis factor-alpha on the proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia (BCP-ALL): studies of primary leukemic cells and BCP-ALL cell lines.
    Zhou MX; Findley HW; Ma LH; Zaki SR; Hill T; Hamid M; Hooper WC; Ragab AH
    Blood; 1991 May; 77(9):2002-7. PubMed ID: 2018837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
    Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
    Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
    Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
    Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
    Uckun FM; Haissig S; Ledbetter JA; Fidler P; Myers DE; Kuebelbeck V; Weisdorf D; Gajl-Peczalska K; Kersey JH; Ramsay NK
    Blood; 1992 Jun; 79(12):3369-79. PubMed ID: 1375851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
    Naeem S; Bukhari MH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
    Uckun FM; Gaynon P; Sather H; Arthur D; Trigg M; Tubergen D; Nachman J; Steinherz P; Sensel MG; Reaman GR
    Blood; 1997 Apr; 89(7):2488-93. PubMed ID: 9116293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
    Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
    Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Distribution of antigenic aberration in the bone marrow of acute leukemia in complete remission].
    Shin S; Kahng J; Kim M; Lim J; Kim Y; Han K
    Korean J Lab Med; 2008 Feb; 28(1):1-7. PubMed ID: 18309249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.